Treatment of Stomal Incontinence with Coaptite Injections in Continent Cutaneous Urinary Diversions
Purpose: Catheterizable stomal incontinence in continent cutaneous urinary diversions (CCUDs) is a well-documented complication. There are limited reports of using urethral bulking agents in treating stomal incontinence after CCUD. We discuss our experience using Coaptite, an U.S. Food and Drug Administration (FDA)-approved urethral bulking agent, to treat incontinence following CCUD. Methods: We reviewed 16 patients with CCUDs who underwent Coaptite injections between 2012 and 2024. This included ten right colon reservoirs, four native bladders with augmentation plus catheterizable channel, and two revised neobladders who underwent urethrectomy and addition of catheterizable channel. Coaptite was injected near the efferent limb-reservoir junction. Outcomes were categorized as full continence (FC), improved continence (IC), no improved continence (NIC), or worsened continence (WC). Results: Of the 16 patients, 13 (81%) demonstrated positive outcomes in response to Coaptite injections, with 8 (50%) achieving FC, and 5 (31%) IC, with a mean of 2.25 injections per patient. No patients had WC. Among the patients with right colon reservoirs, 9 of 10 had positive outcomes (8 FC, 1 IC). Among those with native bladders or neobladders, 4 of 6 achieved IC, and none achieved FC. By channel type, 7 of the 9 patients with appendiceal channels had positive outcomes (5 FC, 2 IC), whereas 6 of the 7 patients with ileal channels achieved positive outcomes (3 FC, 3 IC). Conclusion: The majority of patients with CCUD-related incontinence experienced improved continence with Coaptite injections. These results support Coaptite as a minimally invasive treatment option for CCUD-related incontinence.
Authors
- Michael F. Basin (ORCID: https://orcid.org/0000-0002-2905-0824)
- Hooman Djaladat (ORCID: https://orcid.org/0000-0002-1984-3556)
- Siamak Daneshmand (ORCID: https://orcid.org/0000-0001-6224-9598)
- Josh Ku (ORCID: https://orcid.org/0000-0002-2560-5036)
- Leilei Xia (ORCID: https://orcid.org/0000-0003-2954-7256)
- David A. Ginsberg (ORCID: https://orcid.org/0000-0002-0402-8970)
- Anosh Dadabhoy (ORCID: https://orcid.org/0009-0003-1578-4901)
- Chirag P. Doshi (ORCID: https://orcid.org/0000-0001-5416-4746)
- Adam Peña
Institutions
- USC Norris Comprehensive Cancer Center (US)
Publication Details
- Journal
- Journal of Endourology
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1177/08927790261508366
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00